Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REVLON INC /DE/REVRQ · Entity 115224 | Director · 10% owner | November 08, 2022 | November 10, 2022 |
| SIGA TECHNOLOGIES INCSIGA · Entity 6205 | Director · 10% owner | November 16, 2016 | November 18, 2016 |
| vTv Therapeutics Inc.VTVT · Entity 6614 | 10% owner | December 20, 2021 | December 21, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REVLON INC /DE/
Report date November 08, 2022 · Filed November 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectOwned through wholly owned corporations | 41,676,969 |
Reported balance
After 2022-11-08 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-11-08 · Sale · Disposed 4,546,352 · Balance 41,676,969 F1: The shares were sold to RCH Holdings Six Inc. by Perelman Trust Company, LLC, over which MacAndrews & Forbes Incorporated ("M&F") exercises voting control, in exchange for cash consideration of $45,463.52. Mr. Perelman is the sole stockholder of M&F. The transaction was effectuated to implement certain philanthropic endeavors for Mr. Perelman. F2: Of the 41,676,969 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly owned subsidiaries; and (ii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold to RCH Holdings Six Inc. by Perelman Trust Company, LLC, over which MacAndrews & Forbes Incorporated ("M&F") exercises voting control, in exchange for cash consideration of $45,463.52. Mr. Perelman is the sole stockholder of M&F. The transaction was effectuated to implement certain philanthropic endeavors for Mr. Perelman.
F2: Of the 41,676,969 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly owned subsidiaries; and (ii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc.
SIGA TECHNOLOGIES INC
Report date November 16, 2016 · Filed November 18, 2016
Jointly reported with MacAndrews & Forbes Inc., MacAndrews & Forbes LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $.0001 Per ShareSEC Table I · non-derivative | IndirectOwned through wholly-owned company | 24,156,358 |
Last balance in matching sequence
After 2016-11-16 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2016-11-16 · Exercise / conversion · Acquired 10,060,643 · Balance 23,591,348 F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2) F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. Row 2 · 2016-11-16 · Grant · Acquired 565,010 · Balance 24,156,358 F4: On October 13, 2016, the Company entered into an investment agreement relating to the Rights Offering (the "Backstop Agreement"), with a direct or indirect subsidiary of the reporting persons ("Buyer") and other persons (together, the "Backstop Parties"). Under the terms of the Backstop Agreement, Buyer agreed to purchase, pursuant to a separate private placement, 79.744% of any unsubscribed shares of Common Stock offered in the Rights Offering, at the same price per share of Common Stock to be paid in the Rights Offering. The Backstop Parties, taken together, were entitled to a fee of $1.76 million for providing the backstop commitment, payable, at the option of the Company, in cash or stock or, subject to the mutual agreement of the parties, other equity securities, with Buyer entitled to 79.744% of that fee. (continued in footnote 5) F5: (continued from footnote 4) The Company delivered a total of 565,010 shares of Common Stock to Buyer in satisfaction of the fee due under the Backstop Agreement, but no other shares were acquired pursuant to the Backstop Agreement. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. |
| Subscription Rights (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2016-11-08 | IndirectOwned through wholly-owned company | 0 |
Reported balance
After 2016-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-16 · Exercise / conversion · Disposed 0 · Balance 0 F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2) F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights. F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 21, 2016, SIGA Technologies, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock, par value $.0001 per share ("Common Stock"), as of the record date of October 12, 2016, to subscribe for up to an aggregate of $35,284,792 in Common Stock. Each subscription right entitled its holder to invest $0.65 towards the purchase of shares of the Company's Common Stock at a subscription price equal to the lower of $1.50 or 85% of the volume weighted average price of the Common Stock during market hours on the expiration date of the Rights Offering, conditioned on the Company obtaining sufficient proceeds from the Rights Offering and a proposed loan transaction to permit the Company to satisfy certain obligations, together with other conditions outside the control of the reporting persons (all, the "Conditions"), (continued in footnote 2)
F2: (continued from footnote 1) as more fully described in the Company's prospectus relating to the Rights Offering filed with the Securities Exchange Commission on October 21, 2016. Accordingly, the reporting persons were entitled to use basic subscription rights to subscribe for up to approximately $8,781,319 in Common Stock. Furthermore, the reporting persons were also entitled to subscribe for additional shares of common stock through an oversubscription process. Upon the expiration of the Rights Offering on November 8, 2016, the subscription price was fixed at $1.50 per share of Common Stock. The Conditions were satisfied on November 16, 2016. The reporting persons exercised their basic subscription in full and oversubscription rights. Pursuant to the reporting persons' basic subscription rights, they acquired 5,854,212 shares of Common Stock. The reporting persons acquired 4,206,431 shares pursuant to their exercise of their oversubscription rights.
F3: Ronald O. Perelman beneficially owns 100% of the common stock of MacAndrews & Forbes Incorporated, which in turn is the sole member of MacAndrews & Forbes LLC. Certain direct or indirect wholly-owned subsidiaries of those reporting persons hold the securities described above.
F4: On October 13, 2016, the Company entered into an investment agreement relating to the Rights Offering (the "Backstop Agreement"), with a direct or indirect subsidiary of the reporting persons ("Buyer") and other persons (together, the "Backstop Parties"). Under the terms of the Backstop Agreement, Buyer agreed to purchase, pursuant to a separate private placement, 79.744% of any unsubscribed shares of Common Stock offered in the Rights Offering, at the same price per share of Common Stock to be paid in the Rights Offering. The Backstop Parties, taken together, were entitled to a fee of $1.76 million for providing the backstop commitment, payable, at the option of the Company, in cash or stock or, subject to the mutual agreement of the parties, other equity securities, with Buyer entitled to 79.744% of that fee. (continued in footnote 5)
F5: (continued from footnote 4) The Company delivered a total of 565,010 shares of Common Stock to Buyer in satisfaction of the fee due under the Backstop Agreement, but no other shares were acquired pursuant to the Backstop Agreement.
vTv Therapeutics Inc.
Report date December 20, 2021 · Filed December 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 36,519,212 |
Reported balance
After 2021-12-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-12-20 · Sale · Disposed 87,000 · Balance 36,519,212 F1: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation ("Thirty Six East"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2) F2: (cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation ("Thirty Six East"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2)
F2: (cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Light & Wonder, Inc.
Report date October 12, 2020 · Filed October 13, 2020
Section 16 reporting ended · disclosed 2020-10-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 8,871,313 |
Reported balance
After 2020-10-12 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-12 · Sale · Disposed 1,964,285 · Balance 8,871,313 F1: Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the "Trust"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 12, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC and SGMS Acquisition Three LLC sold an aggregate of 1,964,285 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the "Trust"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 12, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC and SGMS Acquisition Three LLC sold an aggregate of 1,964,285 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2019 Filed Mar 25, 2019 18:42 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 39,141 | $21.79 | $852,815.85 |
DisclosureSEC source: 0001209191-19-021232 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,778,321 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $21.7883 reported in Column 4 is the weighted average purchase price for the 39,141 shares acquired by the Reporting Person within a range of $21.63 to $21.95 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 18:42 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 35,859 | $21.36 | $765,890.87 |
DisclosureSEC source: 0001209191-19-021232 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,739,180 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $21.3584 reported in Column 4 is the weighted average purchase price for the 35,859 shares acquired by the Reporting Person within a range of $20.63 to $21.62 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 72,671 | $21.06 | $1,530,509.40 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 6 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,703,321 F6 · price: The reported transactions were executed in multiple trades. The purchase price of $21.0608 reported in Column 4 is the weighted average purchase price for the 72,671 shares acquired by the Reporting Person within a range of $20.94 to $21.27 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F7 · balance_after: Of the 45,703,321 shares of Class A Common Stock reported herein, (i) 41,156,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 42,329 | $20.67 | $874,974.29 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 5 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,630,650 F5 · price: The reported transactions were executed in multiple trades. The purchase price of $20.6708 reported in Column 4 is the weighted average purchase price for the 42,329 shares acquired by the Reporting Person within a range of $19.94 to $20.93 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 63,527 | $20.70 | $1,314,900.90 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,588,321 F4 · price: The reported transactions were executed in multiple trades. The purchase price of $20.6983 reported in Column 4 is the weighted average purchase price for the 63,527 shares acquired by the Reporting Person within a range of $20.41 to $21.00 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 71,815 | $19.77 | $1,419,603.01 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,524,794 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $19.7675 reported in Column 4 is the weighted average purchase price for the 71,815 shares acquired by the Reporting Person within a range of $19.42 to $20.40 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 47,979 | $19.03 | $913,141.13 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,452,979 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $19.0321 reported in Column 4 is the weighted average purchase price for the 47,979 shares acquired by the Reporting Person within a range of $18.42 to $19.41 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:43 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 56,679 | $17.87 | $1,012,848.06 |
DisclosureSEC source: 0001209191-19-020894 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 7 Disclosed balance after: 45,405,000 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $17.8699 reported in Column 4 is the weighted average purchase price for the 56,679 shares acquired by the Reporting Person within a range of $17.42 to $18.40 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| March 18, 2019 Filed Mar 19, 2019 17:42 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | Not disclosed Strike: $1.65 | Not disclosed |
DisclosureSEC source: 0001140361-19-005231 · form4.xml · derivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 5,454,545 shares Expires 2020-03-18 F1 · kind: On March 18, 2019, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $9.0 million. F1 · price: On March 18, 2019, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $9.0 million. F2 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 16:11 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-19-014460 · doc4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 815,217 shares Expires 2019-12-11 F2 · kind: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 28, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F2 · balance_after: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 28, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 16:11 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 815,217 | $1.84 | $1,499,999.28 |
DisclosureSEC source: 0001209191-19-014460 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 16,493,653 F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| February 14, 2019 Filed Feb 15, 2019 09:27 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001140361-19-003319 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 815,217 shares Expires 2019-12-11 F2 · kind: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 14, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F2 · balance_after: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 14, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| February 14, 2019 Filed Feb 15, 2019 09:27 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 815,217 | $1.84 | $1,499,999.28 |
DisclosureSEC source: 0001140361-19-003319 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 15,678,436 F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:31 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001140361-19-001940 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 815,217 shares Expires 2019-12-11 F2 · kind: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 29, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F2 · balance_after: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 29, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:31 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 815,217 | $1.84 | $1,499,999.28 |
DisclosureSEC source: 0001140361-19-001940 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 14,863,219 F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 16:35 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001140361-19-001287 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 815,217 shares Expires 2019-12-11 F2 · kind: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 16, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F2 · balance_after: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 16, 2019, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| January 16, 2019 Filed Jan 18, 2019 16:35 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 815,217 | $1.84 | $1,499,999.28 |
DisclosureSEC source: 0001140361-19-001287 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 14,048,002 F1 · ownership.nature: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 17:24 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 10,000 | $25.15 | $251,489.00 |
DisclosureSEC source: 0001209191-19-000367 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 45,348,821 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $25.1489 reported in Column 4 is the weighted average purchase price for the 10,000 shares acquired by the Reporting Person within a range of $24.90 to $25.25 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F2 · balance_after: Of the 45,348,321 shares of Class A Common Stock reported herein, (i) 40,801,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F. Read SEC document |
| December 28, 2018 Filed Dec 31, 2018 12:11 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 100,000 | $17.65 | $1,765,000.00 |
DisclosureSEC source: 0000950157-18-001258 · form4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 36,050,736 F2 · price: The transaction was executed in multiple trades at prices ranging from $17.46 to $17.89. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F3 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 28, 2018 Filed Dec 31, 2018 07:03 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 20,000 | $24.76 | $495,136.00 |
DisclosureSEC source: 0001209191-18-064357 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,338,321 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $24.7568 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $24.35 to $25.00 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F4 · balance_after: Of the 45,338,321 shares of Class A Common Stock reported herein, (i) 40,791,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 27, 2018 Filed Dec 27, 2018 20:00 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001140361-18-045975 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 815,217 shares Expires 2019-12-11 F2 · kind: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 27, 2018, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F2 · balance_after: On December 11, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 27, 2018, the Issuer exercised its right to have M&F Group purchase 815,217 shares of Common Stock for a total purchase price of $1,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 27, 2018 Filed Dec 27, 2018 20:00 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | PurchaseClass A common stock | 815,217 | $1.84 | $1,499,999.28 |
DisclosureSEC source: 0001140361-18-045975 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,232,785 F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 12:11 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 300,000 | $16.93 | $5,079,000.00 |
DisclosureSEC source: 0000950157-18-001258 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 35,950,736 F1 · price: The transaction was executed in multiple trades at prices ranging from $16.52 to $17.40. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F3 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 07:03 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 33,500 | $24.35 | $815,641.25 |
DisclosureSEC source: 0001209191-18-064357 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,318,321 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $24.3475 reported in Column 4 is the weighted average purchase price for the 33,500 shares acquired by the Reporting Person within a range of $23.96 to $24.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 07:03 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 1,500 | $23.80 | $35,698.95 |
DisclosureSEC source: 0001209191-18-064357 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,284,821 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $23.7993 reported in Column 4 is the weighted average purchase price for the 1,500 shares acquired by the Reporting Person within a range of $23.68 to $23.95 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 26, 2018 Filed Dec 27, 2018 02:35 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 100,000 | $17.11 | $1,711,000.00 |
DisclosureSEC source: 0000950157-18-001245 · form4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 35,650,736 F3 · price: The transaction was executed in multiple trades at prices ranging from $16.74 to $17.37. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F4 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 26, 2018 Filed Dec 26, 2018 20:39 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 32,900 | $23.29 | $766,208.10 |
DisclosureSEC source: 0001209191-18-064138 · doc4.xml · nonDerivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 45,283,321 F4 · price: The reported transactions were executed in multiple trades. The purchase price of $23.289 reported in Column 4 is the weighted average purchase price for the 32,900 shares acquired by the Reporting Person within a range of $22.76 to $23.70 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F5 · balance_after: Of the 45,283,321 shares of Class A Common Stock reported herein, (i) 40,736,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 26, 2018 Filed Dec 26, 2018 20:39 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 2,100 | $22.61 | $47,470.92 |
DisclosureSEC source: 0001209191-18-064138 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 45,250,421 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $22.6052 reported in Column 4 is the weighted average purchase price for the 2,100 shares acquired by the Reporting Person within a range of $22.48 to $22.74 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 02:35 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 139,442 | $16.33 | $2,277,087.86 |
DisclosureSEC source: 0000950157-18-001245 · form4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 35,550,736 F2 · price: The transaction was executed in multiple trades at prices ranging from $16.00 to $16.90. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F4 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 24, 2018 Filed Dec 27, 2018 02:35 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 60,558 | $15.91 | $963,477.78 |
DisclosureSEC source: 0000950157-18-001245 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 35,411,294 F1 · price: The transaction was executed in multiple trades at prices ranging from $15.71 to $15.99. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F4 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 24, 2018 Filed Dec 26, 2018 20:39 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 22,933 | $23.12 | $530,288.93 |
DisclosureSEC source: 0001209191-18-064138 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 45,248,321 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $23.1234 reported in Column 4 is the weighted average purchase price for the 22,933 shares acquired by the Reporting Person within a range of $22.76 to $23.67 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 24, 2018 Filed Dec 26, 2018 20:39 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 2,067 | $22.66 | $46,847.52 |
DisclosureSEC source: 0001209191-18-064138 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 5 Disclosed balance after: 45,225,388 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $22.6645 reported in Column 4 is the weighted average purchase price for the 2,067 shares acquired by the Reporting Person within a range of $22.56 to $22.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 21, 2018 Filed Dec 21, 2018 23:30 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 400,000 | $15.09 | $6,036,000.00 |
DisclosureSEC source: 0000950157-18-001240 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 35,350,736 F1 · price: The transaction was executed in multiple trades at prices ranging from $14.82 to $15.33. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F2 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 21, 2018 Filed Dec 21, 2018 18:33 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 52,756 | $23.24 | $1,226,186.61 |
DisclosureSEC source: 0001209191-18-063994 · doc4.xml · nonDerivative · entry 5 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 6 Disclosed balance after: 45,223,321 F5 · price: The reported transactions were executed in multiple trades. The purchase price of $23.2426 reported in Column 4 is the weighted average purchase price for the 52,756 shares acquired by the Reporting Person within a range of $22.94 to $23.85 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F6 · balance_after: Of the 45,223,321 shares of Class A Common Stock reported herein, (i) 40,676,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 21, 2018 Filed Dec 21, 2018 18:33 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 2,244 | $22.87 | $51,310.86 |
DisclosureSEC source: 0001209191-18-063994 · doc4.xml · nonDerivative · entry 4 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 6 Disclosed balance after: 45,170,565 F4 · price: The reported transactions were executed in multiple trades. The purchase price of $22.8658 reported in Column 4 is the weighted average purchase price for the 2,244 shares acquired by the Reporting Person within a range of $22.78 to $22.94 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 20, 2018 Filed Dec 20, 2018 23:56 UTC | Light & Wonder, Inc. SGMS · Entity 9758 | PurchaseCommon Stock | 200,000 | $15.63 | $3,126,000.00 |
DisclosureSEC source: 0000950157-18-001236 · form4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 34,950,736 F1 · price: The transaction was executed in multiple trades at prices ranging from $15.37 to $15.84. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. F2 · ownership.nature: Mr. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder of each of SGMS Acquisition Corporation, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MFV Holdings One LLC, RLX Holdings Two LLC and MacAndrews & Forbes Group, LLC, which hold the securities described above. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 18:33 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 21,970 | $24.04 | $528,055.54 |
DisclosureSEC source: 0001209191-18-063994 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 6 Disclosed balance after: 45,168,321 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $24.0353 reported in Column 4 is the weighted average purchase price for the 21,970 shares acquired by the Reporting Person within a range of $23.83 to $24.40 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 18:33 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 3,030 | $23.41 | $70,928.36 |
DisclosureSEC source: 0001209191-18-063994 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 6 Disclosed balance after: 45,146,351 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $23.4087 reported in Column 4 is the weighted average purchase price for the 3,030 shares acquired by the Reporting Person within a range of $22.86 to $23.82 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 18:33 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 20,000 | $23.95 | $479,076.00 |
DisclosureSEC source: 0001209191-18-063994 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 6 Disclosed balance after: 45,143,321 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $23.9538 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $23.55 to $24.25 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 18, 2018 Filed Dec 18, 2018 19:16 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 17,230 | $24.41 | $420,532.61 |
DisclosureSEC source: 0001209191-18-063331 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 45,123,321 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $24.4070 reported in Column 4 is the weighted average purchase price for the 17,230 shares acquired by the Reporting Person within a range of $23.81 to $24.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 45,123,321 shares of Class A Common Stock reported herein, (i) 40,576,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 18, 2018 Filed Dec 18, 2018 19:16 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 100 | $23.68 | $2,367.75 |
DisclosureSEC source: 0001209191-18-063331 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 45,106,091 Read SEC document |
| December 17, 2018 Filed Dec 18, 2018 19:16 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 7,670 | $24.24 | $185,955.32 |
DisclosureSEC source: 0001209191-18-063331 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 45,105,991 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $24.2445 reported in Column 4 is the weighted average purchase price for the 7,670 shares acquired by the Reporting Person within a range of $23.80 to $24.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 17:50 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 10,177 | $24.39 | $248,242.47 |
DisclosureSEC source: 0001209191-18-062293 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 45,098,321 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $24.3925 reported in Column 4 is the weighted average purchase price for the 10,177 shares acquired by the Reporting Person within a range of $24.24 to $24.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F3 · balance_after: Of the 45,098,321 shares of Class A Common Stock reported herein, (i) 40,551,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 16:31 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCommon Stock Purchase Warrant · Derivative | 1 | Not disclosed Strike: $2.12 | Not disclosed |
DisclosureSEC source: 0001140361-18-045004 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 340,534 shares Expires 2025-12-11 F2 · kind: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 340,534 shares of Common Stock, exercisable at a price of $2.12, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 11, 2025. F2 · price: In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the "Warrant") to purchase 340,534 shares of Common Stock, exercisable at a price of $2.12, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 11, 2025. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 16:31 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | Not disclosed Strike: $1.84 | Not disclosed |
DisclosureSEC source: 0001140361-18-045004 · form4.xml · derivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A common stock · 5,434,782 shares Expires 2019-12-11 F1 · kind: On December 11, 2018, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F1 · price: On December 11, 2018, MacAndrews & Forbes Group LLC ("M&F Group") entered into a letter agreement (the "Letter Agreement"), with vTv Therapeutics Inc. (the "Issuer"), for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period after the date of the Letter Agreement (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group (whether at its or the Issuer's option) pursuant to the Letter Agreement is limited to $10.0 million. F3 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of M&F Group. M&F Group holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 17:50 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 11,014 | $24.42 | $268,928.84 |
DisclosureSEC source: 0001209191-18-062293 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 3 Disclosed balance after: 45,088,144 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $24.4170 reported in Column 4 is the weighted average purchase price for the 11,014 shares acquired by the Reporting Person within a range of $24.04 to $24.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 08:30 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 43,770 | $24.24 | $1,060,936.65 |
DisclosureSEC source: 0001209191-18-061671 · doc4.xml · nonDerivative · entry 3 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,077,130 F3 · price: The reported transactions were executed in multiple trades. The purchase price of $24.2389 reported in Column 4 is the weighted average purchase price for the 43,770 shares acquired by the Reporting Person within a range of $23.60 to $24.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. F4 · balance_after: Of the 45,077,130 shares of Class A Common Stock reported herein, (i) 40,530,778 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated ("M&F"), of which Ronald O. Perelman is the sole stockholder, or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 08:30 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 25,335 | $24.23 | $613,915.19 |
DisclosureSEC source: 0001209191-18-061671 · doc4.xml · nonDerivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,033,360 F2 · price: The reported transactions were executed in multiple trades. The purchase price of $24.2319 reported in Column 4 is the weighted average purchase price for the 25,335 shares acquired by the Reporting Person within a range of $23.70 to $24.40 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 08:30 UTC | REVLON INC /DE/ REV · Entity 115224 | PurchaseClass A Common Stock | 5,895 | $23.27 | $137,180.19 |
DisclosureSEC source: 0001209191-18-061671 · doc4.xml · nonDerivative · entry 1 PERELMAN RONALD O · CIK 0001186472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 4 Disclosed balance after: 45,008,025 F1 · price: The reported transactions were executed in multiple trades. The purchase price of $23.2706 reported in Column 4 is the weighted average purchase price for the 5,895 shares acquired by the Reporting Person within a range of $22.89 to $23.69 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above. Read SEC document |
| November 29, 2018 Filed Nov 30, 2018 16:30 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | OtherCall Option (right to buy) · Derivative | 1 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001140361-18-044269 · form4.xml · derivative · entry 2 PERELMAN RONALD O · CIK 0001186472 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A common stock · 1,879,700 shares Expires 2019-07-30 F2 · kind: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 29, 2018, the Issuer exercised its right to have M&F Group purchase the final 1,879,700 shares of Common Stock for a total purchase price of $2,500,000 in cash. F2 · balance_after: On July 30, 2018, M&F Group entered into a letter agreement (the "Letter Agreement"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the "Investment Period"), the Company's Class A common stock, par value $0.01 per share ("Common Stock") at a per share price of $1.33, which is equal to the average of the volume weighted-average prices of the Common Stock for the five last completed trading days preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 29, 2018, the Issuer exercised its right to have M&F Group purchase the final 1,879,700 shares of Common Stock for a total purchase price of $2,500,000 in cash. F1 · ownership.nature: Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.